Home > Insider Trading > Filing (0000950170-24-127275)

Filing Details

Accession Number:: 0000950170-24-127275
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-14 18:01:09
Reporting Period:: 2024-11-12

Accepted Time:: 2024-11-14 18:01:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1521548	Michael Halstead	C/O Intra-Cellular Therapies, Inc. 135 Route 202/206, Suite 6 Bedminster NJ 07921	President	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-11-12	22,869	$23.94	22,869	No	4	M	Direct
Common Stock	Disposition	2024-11-12	15,105	$88.72	7,764	No	4	S	Direct
Common Stock	Disposition	2024-11-12	6,116	$89.63	1,648	No	4	S	Direct
Common Stock	Disposition	2024-11-12	1,648	$90.89	0	No	4	S	Direct
Common Stock	Acquisiton	2024-11-13	18,714	$36.89	18,714	No	4	M	Direct
Common Stock	Disposition	2024-11-13	13,371	$88.17	5,343	No	4	S	Direct
Common Stock	Disposition	2024-11-13	5,343	$88.92	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2024-11-12	22,869	$0.00	22,869	$23.94
Common Stock	Stock Option (right to buy)	Disposition	2024-11-13	18,714	$0.00	18,714	$36.89

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2030-02-17	No	4	M	Direct
0		2031-02-22	No	4	M	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.26 to $89.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.26 to $90.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.32 to $91.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.635 to $88.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.6574 to $89.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
All shares underlying this option have vested.